Wall Street analysts expect Travelers Companies Inc (NYSE:TRV) to report sales of $7.24 billion for the current quarter, according to Zacks. Four analysts have issued estimates for Travelers Companies’ earnings, with estimates ranging from $7.16 billion to $7.34 billion. Travelers Companies posted sales of $6.94 billion during the same quarter last year, which suggests a positive year over year growth rate of 4.3%. The company is expected to announce its next earnings report on Thursday, April 19th.
On average, analysts expect that Travelers Companies will report full year sales of $7.24 billion for the current fiscal year, with estimates ranging from $29.08 billion to $29.70 billion. For the next fiscal year, analysts anticipate that the company will post sales of $30.49 billion per share, with estimates ranging from $30.23 billion to $30.85 billion. Zacks’ sales averages are an average based on a survey of sell-side analysts that cover Travelers Companies.
Travelers Companies (NYSE:TRV) last issued its quarterly earnings results on Tuesday, January 23rd. The insurance provider reported $2.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.56 by ($0.28). Travelers Companies had a net margin of 7.13% and a return on equity of 8.61%. The business had revenue of $7.45 billion for the quarter, compared to analysts’ expectations of $6.47 billion. During the same period last year, the business earned $3.20 earnings per share. The company’s revenue was up 3.6% on a year-over-year basis.
A number of research analysts recently issued reports on TRV shares. Royal Bank of Canada reissued a “buy” rating and set a $148.00 price target on shares of Travelers Companies in a research report on Friday, December 8th. Keefe, Bruyette & Woods reissued a “buy” rating and set a $152.00 price target on shares of Travelers Companies in a research report on Wednesday, December 6th. Bank of America raised shares of Travelers Companies from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 9th. Zacks Investment Research raised shares of Travelers Companies from a “hold” rating to a “buy” rating and set a $148.00 target price for the company in a report on Friday, January 5th. Finally, ValuEngine cut shares of Travelers Companies from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the stock. Travelers Companies currently has a consensus rating of “Hold” and an average price target of $137.20.
Travelers Companies (NYSE:TRV) opened at $142.30 on Friday. Travelers Companies has a 12-month low of $113.76 and a 12-month high of $150.55. The stock has a market cap of $38,624.21, a PE ratio of 19.47, a P/E/G ratio of 1.90 and a beta of 1.29. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.39 and a current ratio of 0.39.
The business also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Friday, March 9th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 2.02%. Travelers Companies’s dividend payout ratio is presently 39.40%.
In other news, Vice Chairman Jay S. Benet sold 4,437 shares of Travelers Companies stock in a transaction that occurred on Wednesday, March 7th. The shares were sold at an average price of $140.13, for a total value of $621,756.81. Following the completion of the sale, the insider now directly owns 89,737 shares in the company, valued at $12,574,845.81. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Andy F. Bessette sold 17,000 shares of Travelers Companies stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $142.42, for a total transaction of $2,421,140.00. Following the completion of the sale, the executive vice president now owns 28,327 shares of the company’s stock, valued at $4,034,331.34. The disclosure for this sale can be found here. Insiders sold 182,727 shares of company stock valued at $26,828,165 over the last quarter. Company insiders own 0.82% of the company’s stock.
Several hedge funds have recently made changes to their positions in TRV. Stelac Advisory Services LLC bought a new stake in Travelers Companies during the fourth quarter valued at approximately $101,000. Field & Main Bank bought a new stake in Travelers Companies during the fourth quarter valued at approximately $102,000. Fieldpoint Private Securities LLC bought a new stake in Travelers Companies during the third quarter valued at approximately $106,000. Valeo Financial Advisors LLC bought a new stake in Travelers Companies during the third quarter valued at approximately $108,000. Finally, CNB Bank bought a new stake in Travelers Companies during the fourth quarter valued at approximately $113,000. Hedge funds and other institutional investors own 79.42% of the company’s stock.
About Travelers Companies
The Travelers Companies, Inc is a holding company. The Company’s segments include Business and International Insurance; Bond & Specialty Insurance, and Personal Insurance. Through its subsidiaries, it provides commercial and personal property and casualty insurance products and services. The Business and International Insurance segment offers property and casualty insurance and insurance related services to its clients, in the United States and in Canada, as well as in the United Kingdom, the Republic of Ireland, Brazil and throughout other parts of the world.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Travelers Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Travelers Companies and related companies with MarketBeat.com's FREE daily email newsletter.